MDT
101.85
+2.05%↑
A
139.48
+1.36%↑
VEEV
222.48
+1.7%↑
HQY
87.09
+2.94%↑
NEOG
9.97
+3.96%↑
MDT
101.85
+2.05%↑
A
139.48
+1.36%↑
VEEV
222.48
+1.7%↑
HQY
87.09
+2.94%↑
NEOG
9.97
+3.96%↑
MDT
101.85
+2.05%↑
A
139.48
+1.36%↑
VEEV
222.48
+1.7%↑
HQY
87.09
+2.94%↑
NEOG
9.97
+3.96%↑
MDT
101.85
+2.05%↑
A
139.48
+1.36%↑
VEEV
222.48
+1.7%↑
HQY
87.09
+2.94%↑
NEOG
9.97
+3.96%↑
MDT
101.85
+2.05%↑
A
139.48
+1.36%↑
VEEV
222.48
+1.7%↑
HQY
87.09
+2.94%↑
NEOG
9.97
+3.96%↑
24h
Current
Min
12.59
Max
13.57
Recommendations | Buy |
|---|---|
12 Months Forecast | +31.94% upside |
Next Earnings | 2 mar 2026 |
|---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
5 lis 2025, 11:36 UTC
Biohaven Shares Slide Premarket After FDA Rejects Vyglxia
DJ
Read
14 maj 2025, 23:25 UTC
Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 16.73 USD 31.94%
High 30 USD
Low 9 USD
Based on 14 Wall Street analysts offering 12 month price targets forBiohaven Pharmaceutical Holding Co Ltd - Dist in the last 3 months.
By TipRanks
Buy
14 ratings
9
Buy
5
Hold
0
Sell
Based on 14 analysts giving stock ratings to Biohaven Pharmaceutical Holding Co Ltd - Dist in the past 3 months.
$